Enhancing non-viral genome editing, processing, and expansion of T and NK cells

Sung (Sung-Uk) Lee, PhD is a Scientist at Thermo Fisher Scientific where he focuses on non-viral delivery for cell and gene therapy applications. Dr. Lee received his PhD in Medical Immunology from University of California, Irvine and performed his postdoctoral work at City of Hope, Brigham and Women’s Hospital (Harvard Medical School) and UCSF Medical Center. He also worked in two start-ups (Pro-Drug/Immuno-Oncology related) prior to joining Thermo Fisher.

Deepak Kumar, Ph.D. is a scientist III at Thermo Fisher Scientific where he focuses on NK cell gene editing using viral and non-viral approaches to support cell and gene therapy workflow applications. Dr. Kumar received his Ph.D. in Molecular Biology and Genetic Engineering from the Institute of Life Sciences (Department of Biotechnology, Government of India), India. After his Ph.D., he joined as Postdoctoral Fellow at Moores Cancer Center, University of California, San Diego and then worked as Project Scientist at the Department of Medicine, University of California, San Diego.